Ascot pays pounds 30m for stake in ChiroTech
Tuesday 11 August 1998
The sale of the minority stake in ChiroTech, which develops complex compounds for pharmaceutical companies, triggered a rally in Chiroscience shares. The stock closed up 3 per cent to 225.5p. Ascot shares rose 12.5p to 273.5p.
Chiroscience said that the sale of the stake in ChiroTech would bring its cash reserves for the year to pounds 60m, enough to pay for at least two years of drug research spending. Chiroscience spends around pounds 18m a year on research, but costs tend to rise during clinical trials.
Like most biotechnology companies, Chiroscience reports losses in the early stages of drug development in the hope of recouping the money when the compound is sold on the market. John Padfield, the chief executive, said: "This deal proves once and for all we don't have to go back to the stockmarket to raise more cash."
He said Chiroscience could sell the remaining 70 per cent of ChiroTech, which revenues of pounds 16m and operating profits of pounds 7.1m last year, if it needed to raise more cash. The company hopes to win approval for its first major drug, the anaesthetic Chirocaine, later this year
Ascot, a pounds 250m-a-year business with interests in chemicals and engineering, said the deal would strengthen its existing drug-making businesses.
- 1 Howard Jacobson: Let's see the 'criticism' of Israel for what it really is
- 2 Instagram of US airport security chiefs: Lipstick knives and IED training kits among items seized
- 3 Brazil vs Germany World Cup 2014: In defence of Mesut Ozil - the Arsenal midfielder works magic in the shadows
- 4 PornHub begs users to stop uploading video clips of Brazil getting beaten 7-1
- 5 Tony Abbott embarrasses Australia by praising Japanese WWII military, ‘getting on the sake’ and posing for ‘crotch-shot’ photo opportunity
Game of Thrones author George RR Martin says 'f*** you' to fans who fear he will die before finishing Westeros saga
Jennifer Lawrence face palms Emma Watson at Christian Dior show in Paris
Instagram of US airport security chiefs: Lipstick knives and IED training kits among items seized
Mick Jagger denies being World Cup curse and reason for Brazil’s embarrassing defeat
Gingers face extinction due to climate change, scientists warn
Sustained immigration has not harmed Britons' employment, say government advisers
British jihadist calls for 'flag of Islam' over Downing Street and Buckingham Palace
Australia facing international condemnation after turning around Sri Lankans at sea
7/7 memorial defaced on anniversary of 2005 attacks with ‘Blair lied thousands died’ graffiti
Even when it brutalises one of its own teenage citizens, America is helpless against Israel
There’s a nasty smell in the political air – and it’s coming from the Tories
iJobs Money & Business
£60000 - £75000 per annum: Harrington Starr: Business Analyst Consultant (Fina...
£60000 per annum: Harrington Starr: A leading provider in investment managemen...
£600 - £700 per day: Harrington Starr: AVS, JVS Openlink Endur Developer JVS, ...
£30000 per annum: Harrington Starr: A global leader in trading platforms and e...